Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,520.00p
   
  • Change Today:
      14.00p
  • 52 Week High: 1,885.00
  • 52 Week Low: 1,135.00
  • Currency: UK Pounds
  • Shares Issued: 135.51m
  • Volume: 647,982
  • Market Cap: £2,059.74m
  • RiskGrade: 314

Indivior profits fall on higher costs ahead of US listing

By Frank Prenesti

Date: Thursday 28 Jul 2022

LONDON (ShareCast) - (Sharecast News) - Pharmaceutical company Indivior reported a fall in interim profits due to rising costs.
The firm on Thursday said pre-tax profit fell to $106m from $119m a year earlier.

However, revenue for the period increased to $428m from $381m year on year and the company held net revenue and adjusted operating income guidance for the full year.

It also increased full year guidance for its sublocade drug to $420m from $390m.

Indivior guided for pre-tax costs of $10m - $15m as it prepared for an additional US listing, with around 50% expected to be recorded as a one-off.

Reporting by Frank Prenesti at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,520.00p
Change Today 14.00p
% Change 0.93 %
52 Week High 1,885.00
52 Week Low 1,135.00
Volume 647,982
Shares Issued 135.51m
Market Cap £2,059.74m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.38% below the market average55.38% below the market average55.38% below the market average55.38% below the market average55.38% below the market average
47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average
Price Trend
68.71% above the market average68.71% above the market average68.71% above the market average68.71% above the market average68.71% above the market average
64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average
Income Not Available
Growth
50.39% above the market average50.39% above the market average50.39% above the market average50.39% above the market average50.39% above the market average
2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 23-Apr-2024

Time Volume / Share Price
16:35 224 @ 1,520.00p
16:35 129,233 @ 1,520.00p
16:35 257 @ 1,520.00p
16:35 214 @ 1,520.00p
16:35 43 @ 1,520.00p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page